Dr. Mehellou has kindly shared an article on his work with us, which he has called Sneaking phosphorylated molecules into cells: a powerful strategy in drug discovery and biotechnology.
“Phosphorylated synthetic molecules and biomolecules play an important role in health and disease. They have shown great potential as therapeutics and useful biotechnological tools. However, the polar nature of phosphate groups, which limits their (passive) cellular uptake has hindered their use. To address this shortage, a number of phophate prodrugs have been developed. Continue reading
15th September (9 – 11 am) in IBR Seminar Room
Following on from last year’s successful event, it is clear that many in PERCAT would like the opportunity to teach within the College of MDS. This workshop presents the range of teaching opportunities we hope to fill in the next academic year. If you are interested in teaching then training is available. Continue reading
The Multiple Sclerosis (MS) Society has now opened the following funding calls:
- What are the barriers and facilitators to prescribers enabling people with MS access to disease modifying treatments? Commissioned Project.
- What evidence is there that early treatment with aggressive disease modifying treatments improves prognosis for people with MS? UK MS Clinical Trial Network Commissioned Project.
- Deadline for submission is 12 noon, 28 September 2015 for both calls.
We are pleased to announce the Postdoctoral/Early Researcher Career Development and Training Research Gala will be held on Thursday, 19th November 2015 in the Great Hall, Aston Webb, University of Birmingham. This event is in collaboration with Birmingham City University and Aston University.
Registration is free, please complete the online form to register for the Gala. Registration will close on Monday, 9th November. Continue reading
Information about this opportunity can be found at this webpage
The latest version of our funding calendars are now available.
Follow this link to download.
Wouldn’t it be great if you could just have a little peek over the fence to see how other organisations work? Wilma van Riel, Clinical Trials Quality Assurance Manager in MDS, is doing just that through her Universitas 21 Fellowship. She is currently visiting the University of British Columbia in Vancouver, Canada, to learn more about how clinical research is managed and governed in UBC and its affiliated organisations.
Wilma told us, “It is exciting to meet with so many different experts in the field, to hear of their activities and exchange best practices. Already I have learnt so much, and I have taken away plenty of ideas to explore further.”
Wilma has been invited to give a presentation to Canada’s quarterly clinical research network of networks (N2) stakeholders meeting, and a guest lecture for Clinical Research Professionals in British Columbia latter this month. Both events will give unique opportunities to connect with an even larger group of clinical researchers.